|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Market Summary
News
IPOs
Company Profiles
Companies
Events
Research Store
Biotech Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
TG Therapeutics, Inc. (MHA) to Present at Lazard Capital Markets 9th Annual Healthcare Conference
11/13/2012 8:12:12 AM
NEW YORK, Nov. 13, 2012 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (OTCBB:TGTX), an innovative, clinical-stage biopharmaceutical company focused on the acquisition, development and commercialization of medically important pharmaceutical products for the treatment of cancer and other underserved therapeutic needs, today announced that Michael Weiss, the Company's Executive Chairman and Interim Chief Executive Officer, will be presenting at the Lazard Capital Markets 9th Annual Healthcare Conference, being held at the Pierre Hotel in New York City. Mr. Weiss' presentation is scheduled to take place on Wednesday November 14, 2012 at 1:30 PM ET. A webcast of this presentation will be available at www.tgtxinc.com on the Events page under the Investors & Media Tab.
|
|
|
|
|
|
|
|
|
|
|